diseases of intestine Flashcards
(88 cards)
what portion of the GI tract can Crohns disease affect
any portion mouth to anus
50% include terminal ilium and colon
30% with terminal ilium only
20% with colon only
<5% with upper GI tract involvement
what id dysbiosis
alternation in normal flora of the gut
how do you describe inflammation with Crohns
tranmural - aka full thickness
‘cobblestoning’ or ‘skip lesions’
what is the presentation of Crohns
variable - depending on location and severity of dz
many have RUQ pain + diarrhea
+/- systemic symptoms (fever, weight loss, fatigue)
may present with obstruction from strictures, parianal or other GI tract manifestations or extra-intestinal manifestations
what is the workup for crohns disease
no lab testing specific for Crohns
stool studies to r/o other causes of diarrhea
+/- elevated ERC/CRP and evidence of malabsorption
Mainstay of dx is colonoscopy with biopsy
what is ulcerative colitis
like crohns, inflammatory condition but pathogenesis unknown
hereditary risk, environmental risk
what can lower the severity of UC
smoking
where is UC located in the GI tract
confined to colon
25% isolated to recosigmoid region
50% have disease extending to splenic flexure
25% have disease extending more proximally
what is inflammation confied to the mucosa
ulcerative colitis
what is the presentation of UC
variable based on location and severity of dz
-MOST with bloody diarrhea +/- mucus
LLQ, abdominal cramping, fecal urgency, tenesmus
+/- fever, weight loss
+/- extraintestinal manifestations
what is the workup for UC
mainstay of dx is colonoscopy with biopsy
when is colonoscopy with biopsy contraindicated
acute disease - risk for bowel perforation
What is the pharmacologic treatments of crohns and UC
5-aminosalicylates: (5ASA; sulfasalazine, mensalamine, balsalazide)
Corticosteroids
Immunomodulators (Mercaptopurine, azathioprine, methotrexate)
Biologic agents: TNF inhibitors, Anti-integrins, anti-IL antibody
what is the treatment of acute crohns
ensure adequate nutrition
antidiarrheal agents (loperamide)
pharmacotherapy:
mensalamine
+/- oral abx
corticosterioids (budesonide first line)
what is maintenance therapy for crohns
pts usually on zathioprine or mercaptopurine + infliximab
what is the treatment of acute UC
normal oral intake if mild/moderate
AVOID anti-diarrhea (loperamide)
pharmacologic:
topical mesalamine (first line: suppository or enema)
what is fulminant UC disease
severe, rapidly progressive (1-2 weeks) and toxic
fever, hypovolemia, hemorrhage, abdominal distension and tenderness
risk for bowl perforation and toxic megacolon
what is the treatment of fulminant UC disease
NPO 24-48 hours
resuscitation: fluid, blood products, correct electrolytes
topical hydrocortison -> infliximab +/- cyclosporine
R/o Toxic Megacolon with abd xr
what is the first line maintenance tx of UC
continue 5-ASA agent: topical or oral
if no improvement in 4-8 weeks: add pred or methylpred
when is surgical intervention recommended for UC/Crohn’s
refractory UC/Crohns
what are the indications for bowel resection with crohn’s and UC
refractory
hemorrhage
abscess
obstruction
fistulas
bowel perforation
fulminant colitis
toxic megacolon
carcinoma
what is an immunogenic response to gluten
celiac disease
what are gene associations with celiac disease
HLA-DQ2 gene
what is the result of the antibodies with celiac disease
damage to intestinal mucosa (villi)
tissue transflutaminase (tTG) antibodies
anti-gliadin antibodies
anti-endomysial antibodies (EMA)